These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6506373)

  • 21. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiotherapy for stage T3b transitional cell carcinoma of the bladder.
    Pollack A; Zagars GZ
    Semin Urol Oncol; 1996 May; 14(2):86-95. PubMed ID: 8734736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy.
    Cowan RA; McBain CA; Ryder WD; Wylie JP; Logue JP; Turner SL; Van der Voet J; Collins CD; Khoo VS; Read GR
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):197-207. PubMed ID: 15093917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
    Søndergaard J; Høyer M; Petersen JB; Wright P; Grau C; Muren LP
    Acta Oncol; 2009; 48(2):238-44. PubMed ID: 18759144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide.
    Hoskin PJ; Saunders MI; Dische S
    Cancer; 1999 Oct; 86(7):1322-8. PubMed ID: 10506720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intraoperative radiotherapy of bladder carcinoma].
    Fuchs G; Uberall R
    Strahlentherapie; 1968 Mar; 135(3):280-4. PubMed ID: 5724676
    [No Abstract]   [Full Text] [Related]  

  • 27. [Individual determination of prognosis of 2-year survival in the radiation therapy of bladder carcinoma (author's transl)].
    Mardynskij JS; Sterin AU
    Radiobiol Radiother (Berl); 1977; 18(4):441-5. PubMed ID: 601209
    [No Abstract]   [Full Text] [Related]  

  • 28. Organ preservation in invasive bladder cancer: brachytherapy, an alternative to cystectomy and combined modality treatment?
    Pos F; Horenblas S; Dom P; Moonen L; Bartelink H
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):678-86. PubMed ID: 15708245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Interstitial brachytherapy in infiltrating cancer of the bladder. The Nancy experience].
    Hoffstetter S; Hubert J; Guillemin F; Peiffert D; Marchal C; Luporsi E; Pernot M
    Cancer Radiother; 1998 Apr; 2 Suppl 1():54s-61s. PubMed ID: 9749080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformal treatment planning for interstitial brachytherapy.
    Kovács G; Hebbinghaus D; Dennert P; Kohr P; Wilhelm R; Kimmig B
    Strahlenther Onkol; 1996 Sep; 172(9):469-74. PubMed ID: 8830809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bladder-sparing therapy for muscle-infiltrating bladder cancer.
    Pansadoro V; Emiliozzi P
    Nat Clin Pract Urol; 2008 Jul; 5(7):368-75. PubMed ID: 18560383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carcinoma of the urinary bladder category T2,3NXM0 treated by 40 Gy external irradiation followed by cesium137 implant at reduced dose (50%).
    van der Werf-Messing BH; van Putten WL
    Int J Radiat Oncol Biol Phys; 1989 Feb; 16(2):369-71. PubMed ID: 2921141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early complications and survival following short-term palliative radiotherapy in invasive bladder carcinoma.
    Holmäng S; Borghede G
    J Urol; 1996 Jan; 155(1):100-2. PubMed ID: 7490801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of cancers of the bladder by curietherapy].
    Van Der Werf-Messing B
    J Radiol Electrol Med Nucl; 1974 Nov; 55(11):823-7. PubMed ID: 4217829
    [No Abstract]   [Full Text] [Related]  

  • 35. Guidelines for radiation therapy in clinical research on bladder cancer.
    Shipley WU; Van der Schueren E; Kitagawa T; Gospodarowicz MK; Frommhold H; Magno L; Mochizuki S; Van den Bogaert W; Van der Werf-Messing B
    Prog Clin Biol Res; 1986; 221():109-21. PubMed ID: 3809178
    [No Abstract]   [Full Text] [Related]  

  • 36. [Interstitial radiotherapy].
    Hammer J
    Wien Med Wochenschr; 1983 Jun; 133(12):307-9. PubMed ID: 6684364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Split-dose radiotherapy for bladder carcinoma. 94 cases treated from 1960 through 1966.
    Scanlon PW; Furlow WL
    Radiology; 1970 Oct; 97(1):141-8. PubMed ID: 5459347
    [No Abstract]   [Full Text] [Related]  

  • 38. [BCG and radiotherapy: the compatibility of 2 conservative treatments for cancer of the urinary bladder].
    Sánchez-Martín FM; Palou Redorta J; Regalado Pareja R; Rubio Briones J; Villavicencio Mavric H; Vicente Rodríguez J
    Arch Esp Urol; 1999 Sep; 52(7):749-58. PubMed ID: 10540765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical radiobiology of stage T2-T3 bladder cancer.
    Majewski W; Maciejewski B; Majewski S; Suwinski R; Miszczyk L; Tarnawski R
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):60-70. PubMed ID: 15337540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The case for radiotherapy with or without chemotherapy in high-risk superficial and muscle-invading bladder cancer.
    Zietman AL; Shipley WU; Heney NM; Althausen AF
    Semin Urol Oncol; 1997 Aug; 15(3):161-8. PubMed ID: 9394911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.